These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 32313144

  • 1. miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR.
    Ji L, Lin Z, Wan Z, Xia S, Jiang S, Cen D, Cai L, Xu J, Cai X.
    Cell Death Dis; 2020 Apr 20; 11(4):250. PubMed ID: 32313144
    [Abstract] [Full Text] [Related]

  • 2. FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib.
    Gao L, Wang X, Tang Y, Huang S, Hu CA, Teng Y.
    J Exp Clin Cancer Res; 2017 Jan 09; 36(1):8. PubMed ID: 28069043
    [Abstract] [Full Text] [Related]

  • 3. LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription.
    Lin Z, Xia S, Liang Y, Ji L, Pan Y, Jiang S, Wan Z, Tao L, Chen J, Lin C, Liang X, Xu J, Cai X.
    Theranostics; 2020 Jan 09; 10(19):8834-8850. PubMed ID: 32754282
    [Abstract] [Full Text] [Related]

  • 4. SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma.
    Jing Z, Ye X, Ma X, Hu X, Yang W, Shi J, Chen G, Gong L.
    Cancer Med; 2020 Jun 09; 9(12):4324-4338. PubMed ID: 32324343
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway.
    Li TT, Mou J, Pan YJ, Huo FC, Du WQ, Liang J, Wang Y, Zhang LS, Pei DS.
    J Biomed Sci; 2021 Aug 02; 28(1):56. PubMed ID: 34340705
    [Abstract] [Full Text] [Related]

  • 6. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
    Xu H, Zhao L, Fang Q, Sun J, Zhang S, Zhan C, Liu S, Zhang Y.
    PLoS One; 2014 Aug 02; 9(12):e115565. PubMed ID: 25531114
    [Abstract] [Full Text] [Related]

  • 7. MiRNA-124-3p.1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1.
    Dong ZB, Wu HM, He YC, Huang ZT, Weng YH, Li H, Liang C, Yu WM, Chen W.
    Cell Death Dis; 2022 Jan 10; 13(1):35. PubMed ID: 35013144
    [Abstract] [Full Text] [Related]

  • 8. miR-23b-3p Modulating Cytoprotective Autophagy and Glutamine Addiction in Sorafenib Resistant HepG2, a Hepatocellular Carcinoma Cell Line.
    Kaur R, Kanthaje S, Taneja S, Dhiman RK, Chakraborti A.
    Genes (Basel); 2022 Aug 01; 13(8):. PubMed ID: 36011286
    [Abstract] [Full Text] [Related]

  • 9. The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma.
    Zhang Z, Tan X, Luo J, Yao H, Si Z, Tong JS.
    Cell Death Dis; 2020 Oct 23; 11(10):902. PubMed ID: 33097691
    [Abstract] [Full Text] [Related]

  • 10. Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma.
    Lu Y, Chan YT, Tan HY, Zhang C, Guo W, Xu Y, Sharma R, Chen ZS, Zheng YC, Wang N, Feng Y.
    J Exp Clin Cancer Res; 2022 Jan 03; 41(1):3. PubMed ID: 34980204
    [Abstract] [Full Text] [Related]

  • 11. Bacterial metabolite butyrate in modulating sorafenib-targeted microRNAs to curtail its resistance in hepatocellular carcinoma.
    Kumar M, Kaur R, Kanthaje S, Dhiman RK, Chakraborti A.
    J Cancer Res Clin Oncol; 2023 Aug 03; 149(9):5823-5839. PubMed ID: 36583742
    [Abstract] [Full Text] [Related]

  • 12. TRERNA1 upregulation mediated by HBx promotes sorafenib resistance and cell proliferation in HCC via targeting NRAS by sponging miR-22-3p.
    Song W, Zheng C, Liu M, Xu Y, Qian Y, Zhang Z, Su H, Li X, Wu H, Gong P, Li Y, Fan H.
    Mol Ther; 2021 Aug 04; 29(8):2601-2616. PubMed ID: 33839325
    [Abstract] [Full Text] [Related]

  • 13. Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma.
    Shao YY, Chen PS, Lin LI, Lee BS, Ling A, Cheng AL, Hsu C, Ou DL.
    Br J Cancer; 2022 Jun 04; 126(12):1806-1814. PubMed ID: 35236936
    [Abstract] [Full Text] [Related]

  • 14. Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma.
    Tang H, Zhang J, Yu Z, Ye L, Li K, Ding F, Feng X, Meng W.
    Technol Cancer Res Treat; 2017 Dec 04; 16(6):1136-1149. PubMed ID: 29332449
    [Abstract] [Full Text] [Related]

  • 15. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C, Dong X, Zhai B, Jiang X, Dong D, Li B, Jiang H, Xu S, Sun X.
    Oncotarget; 2015 Oct 06; 6(30):28867-81. PubMed ID: 26311740
    [Abstract] [Full Text] [Related]

  • 16. LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells.
    Li W, Dong X, He C, Tan G, Li Z, Zhai B, Feng J, Jiang X, Liu C, Jiang H, Sun X.
    J Exp Clin Cancer Res; 2019 May 03; 38(1):183. PubMed ID: 31053148
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.
    Xu Y, Huang J, Ma L, Shan J, Shen J, Yang Z, Liu L, Luo Y, Yao C, Qian C.
    Cancer Lett; 2016 Feb 28; 371(2):171-81. PubMed ID: 26655273
    [Abstract] [Full Text] [Related]

  • 18. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1.
    Guo XL, Wang HB, Yong JK, Zhong J, Li QH.
    Eur Rev Med Pharmacol Sci; 2018 Oct 28; 22(20):6667-6677. PubMed ID: 30402839
    [Abstract] [Full Text] [Related]

  • 19. CRISPR/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS/SOD1-dependent mitochondrial oxidative stress.
    Lu Y, Chan YT, Wu J, Feng Z, Yuan H, Li Q, Xing T, Xu L, Zhang C, Tan HY, Lee TK, Feng Y, Wang N.
    Drug Resist Updat; 2023 Nov 28; 71():101015. PubMed ID: 37924725
    [Abstract] [Full Text] [Related]

  • 20. LncRNA TTN-AS1 intensifies sorafenib resistance in hepatocellular carcinoma by sponging miR-16-5p and upregulation of cyclin E1.
    Zhou Y, Huang Y, Dai T, Hua Z, Xu J, Lin Y, Han L, Yue X, Ho L, Lu J, Ai X.
    Biomed Pharmacother; 2021 Jan 28; 133():111030. PubMed ID: 33378944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.